Lantheus Holdings (LNTH) FCF Margin Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 253.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1,444.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -990.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2,377.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1,484.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,765.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,067.00 |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.00 |
| Dec 31, 2025 | -1,846.00 |
| Sep 30, 2025 | -1,622.00 |
| Jun 30, 2025 | -592.00 |
| Mar 31, 2025 | 2,390.00 |
| Dec 31, 2024 | 5,837.00 |
| Sep 30, 2024 | 2,956.00 |
| Jun 30, 2024 | -1,097.00 |
| Mar 31, 2024 | 2,193.00 |
| Dec 31, 2023 | 99,453.00 |
| Sep 30, 2023 | 2,306.00 |
| Jun 30, 2023 | -690.00 |
| Mar 31, 2023 | 2,587.00 |
| Dec 31, 2022 | -675.00 |
| Sep 30, 2022 | 1,531.00 |
| Jun 30, 2022 | 995.00 |
| Mar 31, 2022 | 348.00 |
| Dec 31, 2021 | -1,017.00 |
| Sep 30, 2021 | -1,743.00 |
| Jun 30, 2021 | 848.00 |